Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus-Reference-Cited by-同舟云学术

Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus

Author:

Hamed Saher¹,Bennett Charles L.²,Demiot Claire³,Ullmann Yehuda⁴,Teot Luc⁵,Desmoulière Alexis⁶

Affiliation:

1. Remedor Biomed Ltd; Nazareth Israel

2. Hollings Cancer Center of the Medical University of South Carolina; the South Carolina College of Pharmacy; Columbia and Charleston South Carolina

3. Department of Pharmacology; EA 6309; Faculties of Medicine and Pharmacy; University of Limoges; Limoges

4. Department of Physiology; EA 6309; Faculties of Medicine and Pharmacy; University of Limoges; Limoges

5. Department of Plastic & Reconstructive Surgery and Wound Healing; Hospital Lapeyronie; Montpellier France

6. Department of Plastic & Reconstructive Surgery; Rambam Health Care Campus; Haifa Israel

Publisher

Wiley

Subject

Dermatology,Surgery

Link

Reference97 articles.

1. Scott Gavura http://www.sciencebasedmedicine.org/what-does-a-new-drug-cost-part-ii-the-productivity-problem

3. FDA Erythropoietin http://www.accessdata.fda.gov

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献